
PLXDC1 Can Be a Biomarker for Poor Prognosis and Immune Evasion in Gastric Cancer
Author(s) -
Xinwei Li,
Yongfei Fan,
Mingyue Tang,
Huiyuan Li,
Yue Zhang,
Jiaqi Mi,
Yanyan Wang,
Mengmeng Zhao,
Zishu Wang,
Fang Su
Publication year - 2022
Publication title -
journal of inflammation research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.656
H-Index - 33
ISSN - 1178-7031
DOI - 10.2147/jir.s383191
Subject(s) - immune system , immunohistochemistry , cancer , stromal cell , biology , cancer research , biomarker , tumor microenvironment , cd8 , immunology , oncology , medicine , biochemistry
Research has revealed that Plexin domain containing 1 (PLXDC1) is correlated with the prognosis of a variety of tumors, but its role in the tumor microenvironment (TME) of gastric cancer has not been reported.